| node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
| A0A286ZJL9_PIG | PLAU | ENSSSCP00000031778 | ENSSSCP00000010995 | Uncharacterized protein. | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | 0.726 |
| A0A5G2QZ01_PIG | PLAU | ENSSSCP00000070108 | ENSSSCP00000010995 | Uncharacterized protein. | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | 0.817 |
| HRG | PLAU | ENSSSCP00000012572 | ENSSSCP00000010995 | Uncharacterized protein. | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | 0.771 |
| HRG | PLAUR | ENSSSCP00000012572 | ENSSSCP00000052797 | Uncharacterized protein. | Plasminogen activator, urokinase receptor. | 0.750 |
| HRG | PLG | ENSSSCP00000012572 | ENSSSCP00000069662 | Uncharacterized protein. | Plasmin heavy chain A, short form; Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invas [...] | 0.938 |
| HRG | VTN | ENSSSCP00000012572 | ENSSSCP00000020670 | Uncharacterized protein. | Vitronectin; Vitronectin is a cell adhesion and spreading factor found in serum and tissues. Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway (By similarity). | 0.448 |
| MMP9 | PLAU | ENSSSCP00000049256 | ENSSSCP00000010995 | Matrix metalloproteinase-9. | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | 0.785 |
| MMP9 | PLAUR | ENSSSCP00000049256 | ENSSSCP00000052797 | Matrix metalloproteinase-9. | Plasminogen activator, urokinase receptor. | 0.621 |
| MMP9 | PLG | ENSSSCP00000049256 | ENSSSCP00000069662 | Matrix metalloproteinase-9. | Plasmin heavy chain A, short form; Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invas [...] | 0.621 |
| MMP9 | SERPINE1 | ENSSSCP00000049256 | ENSSSCP00000026436 | Matrix metalloproteinase-9. | Plasminogen activator inhibitor 1; Serine protease inhibitor. Inhibits TMPRSS7. Is a primary inhibitor of tissue-type plasminogen activator (PLAT) and urokinase- type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled degradation of blood clots. As PLAU inhibitor, it is involved in the regulation of cell adhesion and spreading. Acts as a regulator of cell migration, independently of its role as protease inhibitor. It is required for stimulation of keratinocyte migration during cutaneous injury repair. I [...] | 0.693 |
| MMP9 | VTN | ENSSSCP00000049256 | ENSSSCP00000020670 | Matrix metalloproteinase-9. | Vitronectin; Vitronectin is a cell adhesion and spreading factor found in serum and tissues. Vitronectin interact with glycosaminoglycans and proteoglycans. Is recognized by certain members of the integrin family and serves as a cell-to-substrate adhesion molecule. Inhibitor of the membrane-damaging effect of the terminal cytolytic complement pathway (By similarity). | 0.646 |
| PLAU | A0A286ZJL9_PIG | ENSSSCP00000010995 | ENSSSCP00000031778 | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | Uncharacterized protein. | 0.726 |
| PLAU | A0A5G2QZ01_PIG | ENSSSCP00000010995 | ENSSSCP00000070108 | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | Uncharacterized protein. | 0.817 |
| PLAU | HRG | ENSSSCP00000010995 | ENSSSCP00000012572 | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | Uncharacterized protein. | 0.771 |
| PLAU | MMP9 | ENSSSCP00000010995 | ENSSSCP00000049256 | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | Matrix metalloproteinase-9. | 0.785 |
| PLAU | PLAUR | ENSSSCP00000010995 | ENSSSCP00000052797 | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | Plasminogen activator, urokinase receptor. | 0.999 |
| PLAU | PLG | ENSSSCP00000010995 | ENSSSCP00000069662 | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | Plasmin heavy chain A, short form; Plasmin dissolves the fibrin of blood clots and acts as a proteolytic factor in a variety of other processes including embryonic development, tissue remodeling, tumor invasion, and inflammation. In ovulation, weakens the walls of the Graafian follicle. It activates the urokinase-type plasminogen activator, collagenases and several complement zymogens, such as C1 and C5. Cleavage of fibronectin and laminin leads to cell detachment and apoptosis. Also cleaves fibrin, thrombospondin and von Willebrand factor. Its role in tissue remodeling and tumor invas [...] | 0.960 |
| PLAU | SERPINB2 | ENSSSCP00000010995 | ENSSSCP00000005261 | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | Plasminogen activator inhibitor 2; Belongs to the serpin family. | 0.785 |
| PLAU | SERPINE1 | ENSSSCP00000010995 | ENSSSCP00000026436 | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | Plasminogen activator inhibitor 1; Serine protease inhibitor. Inhibits TMPRSS7. Is a primary inhibitor of tissue-type plasminogen activator (PLAT) and urokinase- type plasminogen activator (PLAU). As PLAT inhibitor, it is required for fibrinolysis down-regulation and is responsible for the controlled degradation of blood clots. As PLAU inhibitor, it is involved in the regulation of cell adhesion and spreading. Acts as a regulator of cell migration, independently of its role as protease inhibitor. It is required for stimulation of keratinocyte migration during cutaneous injury repair. I [...] | 0.994 |
| PLAU | SERPINE2 | ENSSSCP00000010995 | ENSSSCP00000049148 | Urokinase-type plasminogen activator short chain A; Specifically cleaves the zymogen plasminogen to form the active enzyme plasmin. | SERPIN domain-containing protein; Belongs to the serpin family. | 0.772 |